Micropathology Ltd, University of Warwick
Micropathology Ltd provides clinically supported diagnostics for infections and genetic diseases, supporting the UK transplant population surveillance, and undertaking biomedical research including contract research and clinical trials. The company emphasizes rapid diagnosis, research, and high standards of quality assurance, with accreditation to ISO15189:2012 and recognition through the Queen's Award for Enterprise: Innovation.
Industries
Nr. of Employees
small (1-50)
Micropathology Ltd, University of Warwick
The Venture Centre, University Of Warwick Science Park, Sir William Lyons Road, Coventry, United Kingdom, CV4 7EZ
Services
Laboratory sequencing services including rapid-turnaround Sanger sequencing, short-read high-throughput sequencing, and long-read sequencing offerings for diagnostic and research projects.
Range of molecular assays for rapid pathogen detection, host-response assessment, viral load quantitation, genotyping and drug-resistance testing; capability to develop bespoke molecular assays.
Immunoassay-based testing for detection of specific antibodies or antigens in human and veterinary samples.
Molecular genetic testing services for screening specific mutations and for DNA-based human identification.
Testing services for cell lines and tissue culture materials including contamination screening; provision of cell culture reagents.
Applied research collaborations and contract research services for universities, pharmaceutical companies and investors, including due-diligence research support.
Laboratory sequencing services including rapid-turnaround Sanger sequencing, short-read high-throughput sequencing, and long-read sequencing offerings for diagnostic and research projects.
Range of molecular assays for rapid pathogen detection, host-response assessment, viral load quantitation, genotyping and drug-resistance testing; capability to develop bespoke molecular assays.
Immunoassay-based testing for detection of specific antibodies or antigens in human and veterinary samples.
Molecular genetic testing services for screening specific mutations and for DNA-based human identification.
Testing services for cell lines and tissue culture materials including contamination screening; provision of cell culture reagents.
Applied research collaborations and contract research services for universities, pharmaceutical companies and investors, including due-diligence research support.
Expertise Areas
- Infectious disease diagnostics
- Molecular diagnostics development
- Genomic sequencing and genotyping
- Pathogen surveillance for transplant populations
Key Technologies
- Next-generation short-read sequencing
- Long-read nanopore sequencing
- Sanger sequencing
- Nucleic acid extraction workflows
News & Updates
Launch of a new assay for detecting carbapenem resistance genes.
Transition to new sequencing platforms and methods.
Updates to HIV-1 and HCV testing platforms.
Recent updates to HPV testing procedures.
Introduction of new tests and updates.
Awarded in 2003 for innovation in diagnostics.
Launch of a new assay for detecting carbapenem resistance genes.
Transition to new sequencing platforms and methods.
Updates to HIV-1 and HCV testing platforms.
Recent updates to HPV testing procedures.
Introduction of new tests and updates.
Awarded in 2003 for innovation in diagnostics.